‘He couldn’t walk or remember things’: 25-year-old develops brain damage after bariatric surgery; how thiamine deficiency can strike within days

When questioned about his recent medical history, the patient revealed that he had undergone bariatric (weight loss) surgery ...
The Mirror

James Martin health update after cancer ordeal as he confesses he's been 'kicked down'

James Martin has disclosed that he's been "kicked down" as he shared a health update following his cancer diagnosis seven years ago. The celebrity chef, known for his appearances on United Cakes of ...
WKYC3

Thursday's Daily Dose with Monica Robins: Mental health concerns rise during holidays; diet and Alzheimer's risk and childhood hypertension trends

CLEVELAND — As the holiday season approaches, mental health advocates are reminding families to watch for signs of emotional distress in loved ones, particularly the elderly. The U.S. Surgeon General ...
Hosted on MSN

Thursday's Daily Dose: Mental health concerns rise during holidays; diet and Alzheimer's risk

Health experts urge vigilance for signs of depression and loneliness as the holiday season appoaches. New disclosures show Trump bought bonds affected by government policy changes The Standoff That ...
Pharmabiz

Alembic Pharma receives US FDA final approval for sumatriptan injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, single-dose autoinjector system

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...
Yahoo Finance

Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial

ELMWOOD PARK, N.J., Nov. 4, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch 1 of 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 ...
BBC

'Game-changing' HIV protection jab approved in England and Wales

An injection to prevent HIV is to be offered to patients on the NHS in England and Wales for the first time, bringing the policy in line with Scotland. The long-acting shot, given six times a year or ...
Pharmabiz

ViiV healthcare’s CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced data from the phase I CLARITY open-label, crossover study, showing ...
Finanznachrichten

ViiV Healthcare's CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir

Initial data from the CLARITY study are first to compare acceptability and tolerability of single-dose cabotegravir (CAB) and lenacapavir (LEN) long-acting injections, in 63 HIV-negative adults ...